HK175796A - Oral dosage forms containing pimobendan - Google Patents
Oral dosage forms containing pimobendanInfo
- Publication number
- HK175796A HK175796A HK175796A HK175796A HK175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A
- Authority
- HK
- Hong Kong
- Prior art keywords
- dosage forms
- oral dosage
- forms containing
- pimobendan
- containing pimobendan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Pimobendan dosage forms for oral administration contain citric acid, ensuring constantly good absorption even with large pH variations in the gastrointestinal tract.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4001622A DE4001622A1 (en) | 1990-01-20 | 1990-01-20 | ORAL DRUGS OF PIMOBENDAN |
Publications (1)
Publication Number | Publication Date |
---|---|
HK175796A true HK175796A (en) | 1996-09-27 |
Family
ID=6398467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK175796A HK175796A (en) | 1990-01-20 | 1996-09-19 | Oral dosage forms containing pimobendan |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0439030B1 (en) |
JP (1) | JP2608183B2 (en) |
KR (1) | KR0163056B1 (en) |
AT (1) | ATE87481T1 (en) |
AU (1) | AU630536B2 (en) |
CA (1) | CA2034569C (en) |
DE (2) | DE4001622A1 (en) |
DK (1) | DK0439030T3 (en) |
ES (1) | ES2054379T3 (en) |
FI (1) | FI96274C (en) |
HK (1) | HK175796A (en) |
HU (1) | HU207948B (en) |
IE (1) | IE64659B1 (en) |
IL (1) | IL96995A (en) |
NO (1) | NO176305C (en) |
NZ (1) | NZ236834A (en) |
PT (1) | PT96506B (en) |
ZA (1) | ZA91372B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2753904B1 (en) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE OF ACTIVE SUBSTANCE, INCLUDING A MATRIX, AND MANUFACTURING PROCESS |
DE102004011512B4 (en) | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical preparation containing pimobendan |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
EP1744750A2 (en) * | 2004-05-06 | 2007-01-24 | Sandoz AG | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
JP3996626B2 (en) * | 2004-06-22 | 2007-10-24 | 塩野義製薬株式会社 | Orally disintegrating tablets |
JP4572293B2 (en) * | 2004-07-21 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
JP2006028130A (en) * | 2004-07-21 | 2006-02-02 | Toa Eiyo Ltd | Pimopendan preparation for oral administration |
JP4572296B2 (en) * | 2004-07-21 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
WO2007035874A1 (en) * | 2005-09-21 | 2007-03-29 | Bristol-Myers Squibb Company | Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof |
JP4572300B2 (en) * | 2006-01-19 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
PE20081482A1 (en) * | 2006-12-20 | 2008-12-23 | Novartis Ag | GELATINE CAPSULES CONTAINING AN ACID |
FR2934156B1 (en) | 2008-07-23 | 2010-09-24 | Virbac | ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM |
WO2010055119A2 (en) * | 2008-11-17 | 2010-05-20 | Novartis Ag | Pharmaceutical composition comprising pimobendan |
DK2370070T3 (en) | 2008-11-25 | 2013-12-02 | Boehringer Ingelheim Vetmed | Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats |
NL1037569C2 (en) | 2009-12-18 | 2011-06-21 | Eurovet Animal Health B V | Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use. |
JPWO2011081117A1 (en) * | 2009-12-29 | 2013-05-09 | 興和株式会社 | Solid pharmaceutical composition for oral administration |
TW201129557A (en) * | 2009-12-29 | 2011-09-01 | Kowa Co | Pharmaceutical composition for oral administration |
ES2924478T3 (en) | 2012-03-15 | 2022-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Formulation of pharmaceutical tablets for the veterinary medical sector, method of production and use thereof |
CN105377235A (en) | 2013-07-19 | 2016-03-02 | 勃林格殷格翰动物保健有限公司 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
AU2014359427B2 (en) * | 2013-12-04 | 2017-04-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved pharmaceutical compositions of pimobendan |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
CN106729723A (en) * | 2016-11-21 | 2017-05-31 | 青岛农业大学 | A kind of pharmaceutical composition containing UD-CG115BS.acardi and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2837161A1 (en) * | 1978-08-25 | 1980-03-06 | Thomae Gmbh Dr K | 5-Alkyl:pyridazinyl substd. benzimidazole derivs. - useful as cardiovascular agents, antivirals, interferon inducers and ulcer inhibitors |
ES482789A0 (en) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | PROCEDURE FOR THE PREPARATION OF NEW BENZHIMIDAZOLES REPLACED IN POSITION 5 OR 6 WITH A PYRIDAZINONE RING |
JPS56110612A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Readily disintegrable and absorbable compression molded article of slightly soluble drug |
JPS60163823A (en) * | 1984-02-03 | 1985-08-26 | Taisho Pharmaceut Co Ltd | Oral administration pharmaceutical |
DE3776269D1 (en) * | 1986-11-03 | 1992-03-05 | Schering Corp | LABETALOL TABLET WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES. |
DE3728244A1 (en) * | 1987-08-25 | 1989-03-09 | Thomae Gmbh Dr K | Novel (-)-benzimidazoles, their preparation and medicaments containing these compounds |
EP0306846A3 (en) * | 1987-09-11 | 1990-05-02 | Dr. Karl Thomae GmbH | Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-a2 antagonist, and its use or preparation |
DE3805635A1 (en) * | 1988-02-24 | 1989-09-07 | Thomae Gmbh Dr K | USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT WITH ANTI-MIXIC EFFECTS ON THE HEART AND ITS COMBINATIONS WITH SS-BLOCKERS OR BRADYCARDICA |
JPH01258621A (en) * | 1988-04-06 | 1989-10-16 | Fujimoto Seiyaku Kk | Dilazep tablet with regulated absorption |
JPH023609A (en) * | 1988-06-21 | 1990-01-09 | Fujimoto Seiyaku Kk | Long-acting drug preparation containing nicardipine hydrochloride as active component |
-
1990
- 1990-01-20 DE DE4001622A patent/DE4001622A1/en not_active Withdrawn
-
1991
- 1991-01-11 ES ES91100309T patent/ES2054379T3/en not_active Expired - Lifetime
- 1991-01-11 AT AT91100309T patent/ATE87481T1/en not_active IP Right Cessation
- 1991-01-11 EP EP91100309A patent/EP0439030B1/en not_active Expired - Lifetime
- 1991-01-11 DE DE9191100309T patent/DE59100067D1/en not_active Expired - Lifetime
- 1991-01-11 DK DK91100309.3T patent/DK0439030T3/en active
- 1991-01-17 PT PT96506A patent/PT96506B/en not_active IP Right Cessation
- 1991-01-18 ZA ZA91372A patent/ZA91372B/en unknown
- 1991-01-18 FI FI910263A patent/FI96274C/en active
- 1991-01-18 NO NO910213A patent/NO176305C/en not_active IP Right Cessation
- 1991-01-18 CA CA002034569A patent/CA2034569C/en not_active Expired - Lifetime
- 1991-01-18 AU AU69454/91A patent/AU630536B2/en not_active Expired
- 1991-01-18 KR KR1019910000822A patent/KR0163056B1/en not_active IP Right Cessation
- 1991-01-18 NZ NZ236834A patent/NZ236834A/en unknown
- 1991-01-18 JP JP3004069A patent/JP2608183B2/en not_active Expired - Lifetime
- 1991-01-18 IE IE16591A patent/IE64659B1/en not_active IP Right Cessation
- 1991-01-18 HU HU91177A patent/HU207948B/en unknown
- 1991-01-22 IL IL9699591A patent/IL96995A/en not_active IP Right Cessation
-
1996
- 1996-09-19 HK HK175796A patent/HK175796A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE59100067D1 (en) | 1993-05-06 |
NZ236834A (en) | 1995-10-26 |
EP0439030A2 (en) | 1991-07-31 |
IE64659B1 (en) | 1995-08-23 |
IL96995A0 (en) | 1992-03-29 |
HU207948B (en) | 1993-07-28 |
NO910213L (en) | 1991-07-22 |
CA2034569C (en) | 2002-03-19 |
FI96274C (en) | 1996-06-10 |
JPH04210919A (en) | 1992-08-03 |
EP0439030A3 (en) | 1991-10-16 |
AU6945491A (en) | 1991-07-25 |
ES2054379T3 (en) | 1994-08-01 |
FI910263A0 (en) | 1991-01-18 |
JP2608183B2 (en) | 1997-05-07 |
KR910014120A (en) | 1991-08-31 |
EP0439030B1 (en) | 1993-03-31 |
FI96274B (en) | 1996-02-29 |
ATE87481T1 (en) | 1993-04-15 |
IL96995A (en) | 1994-11-11 |
CA2034569A1 (en) | 1991-07-21 |
HUT56494A (en) | 1991-09-30 |
DK0439030T3 (en) | 1993-08-16 |
NO176305C (en) | 1995-03-15 |
IE910165A1 (en) | 1991-07-31 |
FI910263A (en) | 1991-07-21 |
AU630536B2 (en) | 1992-10-29 |
ZA91372B (en) | 1992-09-30 |
NO176305B (en) | 1994-12-05 |
NO910213D0 (en) | 1991-01-18 |
PT96506B (en) | 1998-06-30 |
HU910177D0 (en) | 1991-08-28 |
DE4001622A1 (en) | 1991-07-25 |
KR0163056B1 (en) | 1998-12-01 |
PT96506A (en) | 1991-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK175796A (en) | Oral dosage forms containing pimobendan | |
ITBO910024A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY. | |
NO20053106D0 (en) | Oral, extended-release analgesic dosage form. | |
DE3882077D1 (en) | HEAT-STABILIZED COPOLYMER COMPOSITION. | |
NO308854B1 (en) | Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof | |
DE69013782D1 (en) | Oxygen impermeable amorphous polyamides. | |
SG65636A1 (en) | Orally administrable pharmaceutical formulations | |
EP0455243A3 (en) | Draft tube, direct contact crystallizer | |
EP0457960A3 (en) | High acid concentration dialysates | |
HUP0101415A3 (en) | 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use | |
NO880780L (en) | DEVICE FOR USE IN THE ORAL HYGIENE. | |
IT8583453A0 (en) | GROUNDBALL TRANSFER UNIT FOR ROLLING MACHINE, TRANSFER FOR BALLAST AND ROLLING MACHINE EQUIPPED AS SO. | |
IT8445702A0 (en) | DEVICE FOR TRANSPORTING FILM FRAMES INTO THE FILM DEVELOPERING MACHINE. | |
ITPS910019A0 (en) | -INSERT FOR ENDOSSEAL IMPLANTOLOGY IN DENTISTRY. | |
EP0575583A4 (en) | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals. | |
FI922496A0 (en) | LINEAERT VISKOELASTISK, VATTENHALTIG, FLYTANDE TVAETTMEDELSKOMPOSITION MED FOERBAETTRAD, HOEG TEMPERATUR- STABILITET, SPECIELLT FOER AUTOMATISKA DISKMASKINER. | |
IT9021846A1 (en) | PRETECTIVE ENVELOPE, PARTICULARLY DESIGNED FOR HOSPITAL USE. | |
FR2654928B1 (en) | BED, ESPECIALLY HOSPITAL BED. | |
ZA928736B (en) | Amino acid derivatives. | |
IE901205L (en) | Amino acid derivatives. | |
AR243389A1 (en) | Automatic endoscopic flowmeter device for providing patients carbon dioxide. | |
IT223688Z2 (en) | BODY FOR CHILDREN WHEELCHAIRS. | |
ZA925765B (en) | Use of di-tert.Butylhydroxyphenyl derivatives for the treatment of the gastrointestinal tract | |
IT9040442A1 (en) | ORAL ANTIGAS RESPIRATOR. | |
ES264842Y (en) | "SLEEPING BAG, PERFECTED". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20110110 |